Younger and middle-aged patients have higher burden of neurologic symptoms, fatigue, sleep disturbance, cognitive dysfunction
Prevalence of Crohn disease higher in males; variation seen in prevalence by race and ethnicity
Semaglutide and liraglutide also linked to reduction in risks for SUD hospitalization, somatic hospitalizations
Large disparities in life expectancy observed, which grew over time, especially during the first two years of COVID-19
Initial strategy of catheter ablation leads to lower risk for composite primary end point versus antiarrhythmic drug therapy
Primary end point not met, but small subset of advanced pancreatic ductal adenocarcinoma patients showed durable responses
34 percent of patients have persistent impairment beyond 36 months, although most have favorable outcome on mRS
Lower risk for composite of death from cardiovascular causes or worsening heart failure seen with tirzepatide versus placebo
More than 39 million U.S. adults qualify for indications other than weight management alone
Highest association seen at five-year lag period, but significant associations also seen at no lag, up to 20-year lag period
Total number of children and adolescents with overweight and obesity expected to reach 43.1 million by 2050
Chronic pain, high-impact chronic pain prevalence increased with age; American Indian and Alaska Native non-Hispanic adults more likely to have chronic pain
Maternal vaccination two to three or three to four weeks before delivery linked to lower cord:maternal transfer ratios versus at least five weeks
Older adults with ADRD and polypharmacy experience more symptoms, have negative health outcomes